Genome sequencing: Omicron found in 248 of 280 samples tested, says BMC

Genome sequencing helps in understanding the difference between two variants of the same virus and makes treatment more effective

Vaccine labratory
Representational image
Press Trust of India
2 min read Last Updated : Jan 24 2022 | 8:21 PM IST
The civic body in Mumbai on Monday said 248 of the 280 samples sent for genome testing have been detected with the Omicron variant of coronavirus, an official said.
 
This was the eighth batch of samples, comprising 280 from civic limits and 93 from outside, that had been sent to check for the presence of Omicron, he said, adding that 21 samples had the Delta derivative and 11 samples were found with other variants of coronavirus.
 
As per the release, of the 280 samples from BMC limits, 96 or 34 per cent were of patients in the 21-40 age group, 79 or 28 per cent were in the 41-60 age group, 69 in the 61-80 age segment, 22 in the 0-20 segment and 14 or five per cent in the 81-plus bracket.
 
"Of these, 13 samples were of patients in the 0-18 age bracket, including two who were less than five years old. Four were in the 6-12 age group, and seven in the 13-18 age bracket. A total of 174 out of 280 patients were fully vaccinated, seven had taken the first dose and 99 were unvaccinated," an official said.
 
Of the seven who had taken only one dose, six had to be hospitalized, including two in the Intensive Care Unit, while 89 of 174 patients who were fully vaccinated had to be admitted in hospital. "A total of 76 of 99 unvaccinated patients had to be hospitalized, 12 required oxygen and five were in the ICU," he said.
 
Genome sequencing helps in understanding the difference between two variants of the same virus and makes treatment more effective, the official added.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusMaharashtraCoronavirus VaccineCoronavirus Tests

Next Story